Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Rovi Corporation (NASDAQ:ROVI)

Rovi Corporation (NASDAQ:ROVI) was in 15 hedge funds’ portfolio at the end of December. ROVI has seen a decrease in support from the world’s most elite money managers lately. There were 16 hedge funds in our database with ROVI holdings at the end of the previous quarter.

In the financial world, there are many metrics shareholders can use to monitor stocks. Some of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best money managers can outperform the market by a healthy margin (see just how much).

Rovi logo

Equally as integral, bullish insider trading activity is a second way to break down the investments you’re interested in. Obviously, there are many incentives for an upper level exec to cut shares of his or her company, but only one, very simple reason why they would initiate a purchase. Plenty of academic studies have demonstrated the valuable potential of this strategy if “monkeys” know what to do (learn more here).

Consequently, it’s important to take a peek at the latest action encompassing Rovi Corporation (NASDAQ:ROVI).

Hedge fund activity in Rovi Corporation (NASDAQ:ROVI)

In preparation for this year, a total of 15 of the hedge funds we track were long in this stock, a change of -6% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were upping their holdings significantly.

Of the funds we track, Glenview Capital, managed by Larry Robbins, holds the biggest position in Rovi Corporation (NASDAQ:ROVI). Glenview Capital has a $139 million position in the stock, comprising 2% of its 13F portfolio. On Glenview Capital’s heels is Seth Klarman of Baupost Group, with a $64 million position; the fund has 2.1% of its 13F portfolio invested in the stock. Remaining peers with similar optimism include Mariko Gordon’s Daruma Asset Management, Joseph A. Jolson’s Harvest Capital Strategies and Jim Simons’s Renaissance Technologies.

Due to the fact that Rovi Corporation (NASDAQ:ROVI) has experienced bearish sentiment from the aggregate hedge fund industry, logic holds that there lies a certain “tier” of hedgies that slashed their entire stakes heading into 2013. Intriguingly, Bruce Kovner’s Caxton Associates LP cut the biggest position of the 450+ funds we monitor, worth about $1 million in stock.. Peter Rathjens, Bruce Clarke and John Campbell’s fund, Arrowstreet Capital, also cut its stock, about $1 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest was cut by 1 funds heading into 2013.

What do corporate executives and insiders think about Rovi Corporation (NASDAQ:ROVI)?

Insider buying is at its handiest when the company we’re looking at has seen transactions within the past half-year. Over the last half-year time period, Rovi Corporation (NASDAQ:ROVI) has seen 1 unique insiders buying, and 2 insider sales (see the details of insider trades here).

With the results exhibited by our research, retail investors must always monitor hedge fund and insider trading sentiment, and Rovi Corporation (NASDAQ:ROVI) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!